Brief: UK's MHRA Approves Dawnzera For Treatment Of Familial Chylomicronemia Syndrome
07/05/2026 15:08
May 7 (Reuters) - UK's MHRA: UK'S MHRA: APPROVES DONIDALORSEN (DAWNZERA) FOR THE TREATMENT OF FAMILIAL CHYLOMICRONEMIA SYNDROME Further company coverage: 4768.T ((Reuters.Briefs@thomsonreuters.com;))